Skip to content

Clinical trials

Squamous Cell Carcinoma of Head and Neck trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Country / region: Canada Clear all

158 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20014
20033
20041
20055
20062
20084
20105
20113
20124
20133
20146
201510
20165
20176
201812
201911
202016
202111
20229
20237
20249
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Recruiting27
Terminated25
Active, not recruiting25
Unknown status4
Withdrawn2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto18
Radiation Therapy Oncology Group14
National Cancer Institute (NCI)7
GlaxoSmithKline6
Merck Sharp & Dohme LLC6
Novartis Pharmaceuticals6
AstraZeneca5
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's5
AbbVie4
Bristol-Myers Squibb4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck158
Head and Neck Neoplasms59
Carcinoma, Non-Small-Cell Lung33
Melanoma21
Neoplasms17
Colorectal Neoplasms16
Triple Negative Breast Neoplasms16
Stomach Neoplasms15
Uterine Cervical Neoplasms15
Carcinoma, Squamous Cell14

Trials

Showing 51 to 75 of 158. Each trial links to its page on Pharma Observatory.

58 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.